Evidence map›Paper›PMID 34003714›Full record

ArticlePediatric hematology and oncology2022

Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series.

Anthony S Zembillas, Stefanie M Thomas, Seth J Rotz, Ilia N Buhtoiarov, Rabi Hanna

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric hematology and oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Anthony S ZembillasPharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
Stefanie M ThomasDepartment of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic Children's, Cleveland, Ohio, USA.ORCID 0000-0003-3225-7129
Seth J RotzDepartment of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic Children's, Cleveland, Ohio, USA.ORCID 0000-0003-2896-1113
Ilia N BuhtoiarovDepartment of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic Children's, Cleveland, Ohio, USA.ORCID 0000-0001-5207-4616
Rabi HannaDepartment of Pediatric Hematology Oncology and Bone Marrow Transplantation, Cleveland Clinic Children's, Cleveland, Ohio, USA.ORCID 0000-0001-7518-309X
Cleveland Clinic · US

Funding

Mentored Career DevelopmentKL2TR001854 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Elizabeth Rhea Erwin Burner, Amy Elizabeth West · 2016 to 2026
$9.0M
Institutional Career Development CoreKL2TR002547 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI DWEIK, RAED A. · 2018 to 2022
$7.7M
NCATS NIH HHS KL2 TR001854NCATS NIH HHS KL2 TR002547
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hematopoietic Stem Cell TransplantationLymphoma, Non-HodgkinMucositisStomatitisFibroblast Growth Factor 7HumansTransplantation ConditioningFibroblast Growth Factor 7

Identifiers

PMID34003714
PMCPMC8711132
OpenAlexW3163324554

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.